Latest market price
13.06
+0.15+1.16%
OverviewShort InterestFilings
CBIOQT22Crescent Biopharma, Inc.·NASDAQ
13.06+1.16%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 27, 2026SC 13GBeneficial ownership statement (passive)
Oct 15, 20268-KCurrent report
Sep 18, 20264Statement of changes in beneficial ownership
Sep 18, 20264Statement of changes in beneficial ownership
Sep 18, 20264Statement of changes in beneficial ownership
Sep 18, 20264Statement of changes in beneficial ownership
Sep 18, 20264Statement of changes in beneficial ownership
Sep 18, 2026S-8Registration of employee benefit securities
Sep 18, 20264Statement of changes in beneficial ownership
Sep 18, 20264Statement of changes in beneficial ownership
Sep 01, 20268-KCurrent report
Aug 31, 2026S-8Registration of employee benefit securities
Aug 26, 20268-KCurrent report
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 07, 20268-KCurrent report
Aug 07, 202610-QQuarterly report
Aug 04, 20263Initial statement of beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Aug 04, 20263Initial statement of beneficial ownership
Aug 03, 2026EFFECTNotice of effectiveness
Jul 31, 2026EFFECTNotice of effectiveness
Jul 30, 2026POS AMPost-effective amendment
Jul 30, 202610-QQuarterly report
Jul 30, 20268-KCurrent report
#1 / 25 of 588
Page
▼
/ 24